Literature DB >> 5647842

Generalized gangliosidosis: beta-galactosidase deficiency.

S Okada, J S O'Brien.   

Abstract

A profound deficiency (10- to 30-fold) of beta-galactosidase activity was found in tissues (liver, spleen, kidney, and brain) from two patients with generalized gangliosidosis; this deficiency is demonstrated as a failure to cleave both p-nitrophenyl-beta-D-galactopyranoside and ganglioside GM(1) labeled with C(14) in the terminal galactose. We believe that this enzymic defect is responsible for the accumulation of ganglioside GM(1) and is the fundamental enzyme defect in generalized gangliosidosis.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5647842     DOI: 10.1126/science.160.3831.1002

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  76 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  GM1 gangliosidosis (type 1) in a cat.

Authors:  C G Barker; W F Blakemore; A Dell; A C Palmer; P R Tiller; B G Winchester
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

3.  GM1-generalized gangliosidosis variant with cardiomegaly.

Authors:  P F Benson; A Barbarik; S P Brown; T P Mann
Journal:  Postgrad Med J       Date:  1976-03       Impact factor: 2.401

4.  The mucopolysaccharidoses.

Authors:  C A Pennock; I C Barnes
Journal:  J Med Genet       Date:  1976-06       Impact factor: 6.318

5.  Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex.

Authors:  M Potier; L Michaud; J Tranchemontagne; L Thauvette
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

Review 6.  Progress in investigations of sphingolipidoses.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

7.  Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased 1H NMR-Linked Metabolomics Strategy.

Authors:  Benita C Percival; Yvonne L Latour; Cynthia J Tifft; Martin Grootveld
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

8.  The separation and characterization of the methylumbelliferyl beta-galactosidases of human liver.

Authors:  P S Cheetham; N E Dance
Journal:  Biochem J       Date:  1976-07-01       Impact factor: 3.857

9.  Corneal clouding in GM1-generalized gangliosidosis.

Authors:  A Babarik; P F Benson; A H Fensom
Journal:  Br J Ophthalmol       Date:  1976-08       Impact factor: 4.638

10.  Gmi-gangliosidosis. A variant with high activity of hepatic neutral beta-galactosidase.

Authors:  Y Suzuki; T Hayakawa; M Yazaki; Y Hiratani
Journal:  Eur J Pediatr       Date:  1976-06-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.